|
|
Article: New European Study Examines the Role of Insulin Resistance in Predicting Cardiovascular Disease.
- Article from:
- PR Newswire
- Article date:
- September 3, 2004
CopyrightCOPYRIGHT 2004 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
LONDON and BRUSSELS, September 3 /PRNewswire/ --
- RISC Study, Largest of its Kind, Reaches Recruitment Milestone
The European Group for the study of Insulin Resistance (EGIR) announced today that the clinical trial recruitment milestone of 1,200 subjects has been reached in the Relationship between Insulin Sensitivity and Cardiovascular disease risk (RISC) study - the largest study using the euglycaemic clamp technique to date to examine whether insulin resistance predicts cardiovascular disease (CVD), as well as future development of type 2 diabetes. This study, co-sponsored by the European Union (EU) and AstraZeneca, began in February 2002, involves 14 ...